1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow CD3 Complex: new trials by email Literature Review of CD3 Complex trials Research Report on CD3 Complex
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunological Tolerance in Patients With Mismatched Kidney Transplants Donor CD34+, CD3+. and belumosudil - End Stage Kidney Disease, Immunological Tolerance | Phase 1 | Active not recruiting | University of California, Los Angeles | 16 | 2023-07-07 | 2025-11-26 |
Kidney Failure, Chronic (1) · Rejection, Psychology (1) · Renal Insufficiency, Chronic (1)
University of California, Los Angeles (1)
United States (1)